A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
מצבים רפואיים
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease · HIV (Human Immunodeficiency Virus)
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
University of Alabama Birmingham, Birmingham, Alabama, United States
Contact: Principal Investigator (Sonya Heath, MD)UC San Diego Altman Clinical and Translational Research Institute, La Jolla, California, United States
Contact: Principal Investigator (Rohit Loomba, MD)University of California, San Francisco, San Francisco, California, United States
Contact: Principal Investigator (Jennifer Price, MD)Atlantic Clinical Research Institute, West Palm Beach, Florida, United States
Contact: Principal Investigator (Hector Bolivar, MD)Indiana University, Indianapolis, Indiana, United States
Contact: Principal Investigator (Samer Gawrieh, MD)Johns Hopkins University, Baltimore, Maryland, United States
Contact: Principal Investigator (Mark Sulkowski, MD)Mt Sinai Health System, New York, New York, United States
Contact: Principal Investigator (Meena Bansal, MD)Duke University Medical Center, Durham, North Carolina, United States
Contact: Principal Investigator (Susanna Naggie, MD)UT Health Houston, Houston, Texas, United States
Contact: Principal Investigator (Jordan Lake, MD)Virginia Commonwealth University, Richmond, Virginia, United States
Contact: Study coordinator (Dianne Boyce Grogan) · dianne.boycegrogan@vcuhealth.org · 1-804-828-2988Contact: Principal Investigator (Richard Sterling, MD)